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Abstract.  The IPL2 gene is known to be required for 
normal polarized cell growth in the budding yeast Sac- 
charomyces cerevisiae. We now show that IPL2 is 
identical to the previously identified BEM2 gene. 
bern2 mutants are defective in bud site selection at 
26°C and localized cell surface growth and organiza- 
tion of the actin cytoskeleton at 37°C. BEM2 encodes 
a protein with a COOH-terminal domain homologous 
to sequences found in several GTPase-activating pro- 
teins,  including human Bcr. The GTPase-activating 
protein-domain  from the Bern2 protein (Bera2p) or hu- 
man Bcr can functionally substitute for Bem2p. The 
Rhol and Rho2 GTPases are the likely in vivo targets 
of Bem2p because bern2 mutant phenotypes can be 
partially  suppressed by increasing the gene dosage of 
RH01 or RH02. 
CDC55 encodes the putative regulatory B subunit of 
protein phosphatase 2A,  and mutations in BEM2 have 
previously been identified as suppressors of the cdc55-1 
mutation.  We show here that mutations in the previ- 
ously identified GRR/ gene can suppress bem2 muta- 
tions, grrl and cdc55 mutants are both elongated in 
shape and cold-sensitive for growth, and cells lacking 
both GRR/and CDC55 exhibit a  synthetic lethal 
phenotype, bern2 mutant phenotypes also can be sup- 
pressed by the SSDI-vl  (also known as SRK1  ) muta- 
tion,  which was shown previously to suppress muta- 
tions in the protein phosphatase-encoding SIT4 gene. 
Cells lacking both BEM2 and SIT4 exhibit a  synthetic 
lethal phenotype even in the presence of the SSDI-vl 
suppressor.  These genetic interactions together suggest 
that protein phosphorylation and dephosphorylation 
play an important  role in the BEM2-mediated process 
of polarized cell growth. 
T  n~ generation  of differentiated cellular subdomains  is 
critical  for the functioning  of many eukaryotic cells. 
A  wide  variety  of cellular  constituents,  including 
plasma membrane proteins, organelles, and cytoskeletal fila- 
ments,  must  be organized  asymmetrically.  The  resulting 
polarization  of cell structures is important, for example, for 
the transmission  of a nerve impulse,  the transport of mole- 
cules across an epithelial  cell, and the crawling  of a fibro- 
blast. The molecular mechanisms  by which cell polarity is 
established are poorly understood, and very little is known 
about how sites of directional  cell growth are selected. 
The development  of cell polarity has been studied exten- 
sively in the budding yeast Saccharomyces cerevisiae (re- 
viewed in Chant and Pringle,  1991; Drubin,  1991; Mad- 
den et al.,  1992). Initiation  of normal cell growth involves 
the selection of a proper bud site on the surface of the ellipti- 
cal cell. The choice of this bud site is nonrandom (Friefelder, 
1960; Chant and Herskowitz, 1991); wild-type haploid cells 
bud from only one pole in an axial fashion (i.e., from sites 
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near the site of the previous cell division),  whereas wild-type 
a/a diploid cells bud in a bipolar fashion (i.e., from either 
pole). After the selection  of a bud site,  subsequent growth 
is localized mostly to this selected site, eventually giving rise 
to a bud. Thus, growth of yeast cells is highly asymmetrical, 
and this is accomplished by localized vesicle fusion and cell 
wall synthesis. 
A number of genes have been identified as being important 
for bud site  selection.  They include  RSRI/BUD1, BUD2, 
BUD3, BUD4, BUD5, CDC3, CDCIO, CDC11, CDC12, 
CDC24, SPA2, and RVS167 (Sloat et al.,  1981; Bender and 
Pringle,  1989; Snyder, 1989; Chant et al., 1991; Chant and 
Herskowitz, 1991; Bauer et al., 1993; Flescher et al., 1993). 
Mutations  in these genes  result  in  the  selection  of inap- 
propriate bud sites for the initiation  of growth but, with the 
exception  of temperature-sensitive  cdc24 mutations at ele- 
vated  temperatures,  do not prevent  the subsequent local- 
ization of growth to these selected sites. RSRI/BUD1 encodes 
a Ras-related small GTP-binding protein that is regulated by 
the Bud2 GTPase-activating  protein and the Bud5 GDP/GTP 
exchange  factor (Chant  et al.,  1991; Powers et al.,  1991; 
Bender,  1993; Park et al.,  1993).  CDC3, CDCIO, CDC11, 
CDC12, and SPA2 encode proteins that appear at presump- 
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1987;  Snyder,  1989;  Ford and  Pringle,  1991; Kim et al., 
1991;  Snyder et al.,  1991).  Cdc3p,  Cdcl0p,  Cdcllp,  and 
Cdcl2p are putative components of the 10-nm neck filaments 
which are required for cytokinesis. 
Once a bud site has been selected, several other genes are 
known  to  be  required  for the  subsequent  localization  of 
growth to this site.  They include CDC24, CDC42, CDC43, 
BEM1, and BEM2 (Sloat et al.,  1981; Adams et al.,  1990; 
Bender and Pringle, 1991; Chant et al.,  1991; Chenevert et 
al.,  1992).  Mutations  in these genes result in large, mul- 
tinucleate, unbudded cells that in most cases have also been 
shown to exhibit delocalized cell surface growth. CDC42 en- 
codes a  Rho-related small  GTP-binding protein (Johnson 
and Pringle, 1990) that is regulated by the Cdc24 GDP/GTP 
exchange factor (Zheng et al.,  1994),  the Bem3 GTPase- 
activating protein (Zheng et al., 1994), and the Cdc43/Ram2 
geranylgeranyltransferase I (Ohya et al., 1993; Trueblood et 
al., 1993). It is concentrated on the plasma membrane at the 
site of bud emergence and also over the surface of the grow- 
ing bud (Ziman et al.,  1993). Bemlp and Rvs167p both con- 
tain  SH3-domains  (Chenevert et al.,  1992;  Bauer et al., 
1993)  similar to those found in signal transducing proteins 
that function at the membrane/cytoskeleton interface (Paw- 
son and Schlessinger,  1993). 
Indeed, putative components of the 10-nm neck filaments 
(see above) and the actin cytoskeleton are known to be im- 
portant for the spatial control of cell growth in yeast. For ex- 
ample, actin (act1) and profilin (pfy/) mutants are defective 
in localized cell surface growth and bud site selection (No- 
vick and Botstein, 1985; Haarer et al.,  1990; Drubin et al., 
1993), and conditional myosin (myo2) mutants become ar- 
rested predominantly as large, unbudded cells and also ex- 
hibit delocalized cell surface growth at their restrictive tem- 
peratures (Johnston et al.,  1991).  Thus,  normal polarized 
cell growth requires the coordinated function of a large num- 
ber of signal transducing proteins and components of differ- 
ent cytoskeletal systems. 
BEM2 was  first identified through its genetic interaction 
with MSB1, which can function as a dosage-dependent sup- 
pressor of the temperature-sensitive (Ts-) ~ growth pheno- 
type of cdc24 and cdc42 bud emergence mutants  (Bender 
and Pringle, 1989). Yeast cells lacking MSB1 have no detect- 
able phenotype but become inviable when BEM1 or BEM2 
is also mutated in these cells (Bender and Pringle, 1991). We 
have previously isolated the Ts- ipl2-1 mutant as a condi- 
tional mutant that gains entire sets of chromosomes at the re- 
strictive growth temperature of 37°C  (Chan and Botstein, 
1993). Cytological studies of this mutant revealed that the 
observed change in chromosome number is associated with 
a failure in bud growth but not DNA replication and nuclear 
division,  ipl2-1 mutants  become  arrested  as  large,  mul- 
tinucleate, unbudded ceils at 37°C. This mutant phenotype 
is  similar  to  that  exhibited  by  a  number  of previously 
identified mutants  (see above),  including bem2.  Here we 
show that IPL2 is identical to BEM2. For this reason, the 
ipl2-1 mutation will be referred to as bern2-101 in this report. 
Bem2p is related in sequence and function to a number of 
GTPase-activating proteins,  and  it  probably  functions  in 
1. Abbreviations used in this paper:  Cs-, cold-sensitive; GAP,  GTPase- 
activating protein; Ts  +, temperature-resistant; Ts-, temperature-sensitive. 
vivo with Rholp and Rho2p, two Ras-related small GTPases 
(Madaule et al.,  1987),  to control polarized cell growth. 
Results  from  the  genetic  analysis  of bem2,  grrl,  cdc55, 
SSD1, and sit4 mutants  further suggest that protein phos- 
phorylation and dephosphorylation may play an important 
role in the BEM2-mediated process of polarized cell growth. 
Materials and Methods 
Strains, Media, and Genetic Methods 
Yeast strains used in this study are listed in Table I. The strain CBY1829-1 
was constructed by integrating, via homologous recombination, the URA3- 
bearing plasmid pCC705 into the genome at the GRR/locus of DBY1829. 
The strains CCY432-1D  and CCY432-15C,  used for identifying extragenic 
suppressor mutations of bern2-101, were derived from a strain carrying the 
URA3 gene integrated next to the SPT2 locus (Chan and Botstein, 1993). 
The diploid strain CBY1830-30  was constructed by a one-step gene disrup- 
tion procedure (Rothstein, 1983),  replacing one of the two BEM2 genes in 
DBY1830 with the bem2-AIO3::LEU2 allele present on pCC394. This dis- 
ruption was confirmed by DNA hybridization with an appropriate probe. 
The Escherichia coli strain DB1142 (leu pro thr hsdR hsdM recA) was rou- 
tinely used as a host for plasmids. 
Rich medium YEPD, synthetic minimal medium SD, and SD medium 
with necessary supplements were prepared as described previously (Sher- 
man  et al.,  1974).  These different media contained glucose as carbon 
source. Cells were routinely grown at 26°C unless otherwise specified. 
Yeast genetic manipulations were performed as described by Sherman et al. 
(1974). 
Isolation of  Extragenic Suppressors of bern2-101 
Spontaneous, temperature-resistant (Ts  +) revertants were isolated by seed- 
ing YEPD plates with about 2  ×  107 bern2-101  cells (CCY109-9C-1  or 
CCY109-1D-1) per plate, and incubating for 3-5 d at 37*C. To ensure that 
each revertant isolated was independent, cells from independent colonies 
grown at 26°C were used to seed each plate, and only one revertant was 
studied per plate. Extragenic suppressors were identified by tetrad analysis 
after mating revertants to bern2-101 strains (CCY432-1D  or CCY432-15C) 
that carry a  URA3 marker next to the SPT2 locus, which is tightly linked 
to bern2-101 (Chan and Botstein, 1993).  Initially,  suppressors were not cho- 
sen on the basis of a cold-sensitive (Cs-) growth phenotype. However, sev- 
eral of them (see Results) turned out to have a Cs- growth phenotype. 
DNA Manipulation 
Functional localization of the cloned BEM2 gene was done by subcloning 
DNA fragments into the low copy number URA3-CEN-plasmid pRS316 
(Sikorski and Hieter,  1989).  pCC394,  used for disruption of BEM2,  was 
constructed in two steps. First, a BamHI site was created in pCC231  (see 
Fig. 2) near the 3' end of BEM2  (at codons 2144-2145)  by site-directed 
mutagenesis (Kunkel  et al.,  1987),  using the primer IPL2.1p:  5'-AGC- 
CAACAGCATGGG_ATCCAGATTA-Y (the mutagenic base is underlined). 
This generated pCC393. The sequence between the XbaI and BamHI sites 
of pCC393  was  then  replaced with  the  '~2-kb  XbaI/BamHl  fragment 
(containing LEU2) of pJJ283 (Jones and Prakash,  1990),  generating pCC- 
394. Codons 115-2144 of BEM2 are missing from the bem2-AIO3::LEU2 
mutant allele present on this plasmid. Plasmid pCC705, used for integration 
of URA3 into the genome at the GRR/ locus, was constructed by cloning 
the "-,3.8-kb BgllI fragment (containing part of GRR/) of pBMI720 (Flick 
and Johnston, 1991) into the BamHI site of the URA3-plasmid YIp5 (Scherer 
and Davis,  1979). 
Plasmids used for the expression of GAP domains were constructed in 
the following way. DNA sequence spanning the putative Bem2-GAP domain 
was amplified from the BEM2-plasmid pCC231 by PCR, using the primers 
IPL2.2p  (5'-CGATAAGCTTGGATCC  AAATGCAACTACACGAC TTA-3') 
and  IPL2.3p  (5'-TCGCGGATCCAAGCTTCAAGGAGAAGAG-33.  The 
PCR product, which contained BamHI sites near both ends, was cleaved 
with BamHI and then cloned into the BamHI site of pG-3 (Schena et al., 
1991).  The resulting plasmid pCC408  allows expression of the COOH- 
terminal 287 residues of Bem2p under the control of the strong TDH3 pro- 
moter. In a similar fashion, the plasmid pCC438, which allows expression 
of the COOH-terminal 304 residues of Bcr, was constructed, using the bcr- 
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Strain  Genotype 
DBY 1829 
DBY1830 
CBY1829-1 
CBY1830-30 
CCY-D1 
CCY-D3 
CCY109-1D-I 
CCY109-9C-1 
CCY354-1C 
CCY355-4C 
CCY362-7B 
CCY363-1C 
CCY363-1D 
CCY374-2D 
CCY416-12D 
CCY432-1D 
CCY432-15C 
CCY450-8A 
CCY469-38A 
CCY469-41A 
CCY471-13C 
CCY475-19A 
CCY487-21D 
CCY488-16A 
CCY802-11C 
CY248 
a  lys2-801  his3-A200 ura3-52  1eu2-3,112  trpl-1 
a/ct  ade2/ +  lys2-801/ +  his3-A2OO/his3-A200  ura3-52/ura3-52  leu2-3,112/leu2-3,112  trp l-1/trp l-I 
ct  lys2-801  his3-A200 ura3-52  1eu2-3,112  trpl-1  URA3 (at GRR1) 
al~  ade2/ +  lys2-801/ +  his3-A2OO/his3-A200  ura3-52/ura3-52  leu2-3,112/leu2-3,112  trpl-1/trpl-1 
bem2-AI O3: :  LEU2/ + 
a/a  ade2/ +  lys2-801/ +  his3-A2OO/his3-A200  ura3-52/ura3-52  leu2-3,112/leu2-3,112  trp l-1/trp l-1  bem2-1Ol /bem2-101 
a/ct  ade2/ade2  his3-A2OO/his3-A200  ura3-52/ura3-52  lys2-Al Ol :  :HIS3: :lys2-AlO2/lys2-A l Ol : :HIS3: :tys2-Al 02 
leu2-AlOl::URA3::leu2-Al02/+  grrl-lO2/grrl-102 
a  ade2  his3-A200 ura3-52  lys2-AlOl::HIS3::lys2-Al02  bern2-101 
ct  ade2  his3-A200 ura3-52  lys2-AlOl::HIS3::lys2-Al02  bern2-101 
c~  ade2  his3-A200 ura3-52  lys2-AlOl::HIS3::lys2-Al02  grrl-102 
ct  ade2 his3-A200 ura3-52  lys2-AlOl::HlS3::lys2-Al02  grrl-103 
ct  ade2 his3-A200 ura3-52  lys2-AlOl::HIS3::lys2-Al02  grrl-lO1 
a  ade2 ura3-52 his4-619 grrl-102 
a  ura3-52 his4-619 grrl-102 
c~  lys2-801  his3-A200 ura3-52  1eu2-3,112  trpt-I  bem2-AIO3::LEU2 
lys2-801  his3-A200 ura3-52  1eu2-3,112  trpl-1  bern2-101 
et  1eu2-3,112  his3-A200 ura3-52  lys2-801  bem2-101  URA3 (at SPT2) 
a  1eu2-3,112  his3-A200 ura3-52  lys2-801  bern2-101  URA3 (at SPT2) 
a  lys2-801  his3-A200 ura3-52  leu2-3,112  grrl::LEU2 
a  lys2-801  his3-A200 ura3-52 1eu2-3,112  grrl::LEU2 
ade2 his3-A200 ura3-52  leu2-3,112  cdc55: :URA3 
a  ade2  his3-A200 ura3-52  leu2-3,112  bern2-101 
his3-A200 ura3-52  leu2-3,112  SSDI-vl  bem2-AIO3::LEU2 
a  ade2  his3-A200 ura3-52  1eu2-3,112  grrl-102 
a  ade2 his3-A200 ura3-52  leu2-3,112  grrl-102  bern2-101 
a  ade2 his3-A200 ura3-52  1eu2-3,112 
a  Asit4::HIS3 SSDl-vl  his3 leu2-3 ura3 
Most of the strains were constructed  specifically for this study, the exceptions being DBY1829 and DBYI830, which are from D. Botstein's laboratory  collection 
(Stanford  University, Stanford,  CA), and CY248,  which is from K. Arndt's laboratory  collection  (Cold Spring Harbor Laboratory,  Cold Spring Harbor, NY). 
The cdc55::URA3 allele was constructed in J. Pringles's laboratory  (University of North Carolina,  Chapel Hill, NC). It contains a replacement of the BglII/BamHI 
DNA fragment representing the 5' half of CDC55 with a DNA fragment containing  URA3. The SSDI-vl  allele present in CCY475-19A  was derived from CY248. 
plasmid bcr-3 (Hariharan and Adams, 1987) as template and the primers 
BCR.lp  (5'-CGCGGATCCAAA~TCCCAGACCCTGAGG-3')  and 
BCR.2p (5'-TCGCGGATCCGGAGATGGAC~ACCT-3'). 
The high copy number URA3-2#-plasmids YEpU-RHO1, YEpU-RHO2, 
and YEpU-CDC42, containing RI-IO1, RH02, and CDC42, respectively, 
were obtained from Y. Ohya (University of Tokyo, Tokyo, Japan) (Qadota 
et al., 1992).  pCC'/43, containing both RHO1 and RH02, was constructed 
by inserting the '~2.7-kb SalI/EagI fragment (containing RH02) of YEpU- 
RHO2 into the SalI/EagI sites of YEpU-RHO1. The high copy number plas- 
mids pOPR3 and pOPR4, containing RIt03 and RIt04, respectively, were 
obtained from Y. Matsui (University of Tokyo, Tokyo, Japan) (Matsui and 
Toh-e,  1992a,b). 
Cytological Techniques 
Some of the cytological experiments were carried out using diploid ceils be- 
cause their larger size makes it easier to visualize the actin and microtubute 
cytoskeletons. Immunofluorescence staining of cells was carried out as de- 
scribed (Pringle et al.,  1989).  Microtubules  were  stained with the rat 
anti-~-tubulin mAb YOL1/34  (Bioproducts for Science, Indianapolis, IN) 
and affinity purified FITC-conjugated goat anti-rat secondary antibodies 
(Organon Teknika Corp., West Chester, PA). Actin was stained with affinity 
purified rabbit anti-actin antibodies (gift of David  Drubin)  and affinity 
purified FITC-conjugated goat anti-rabbit secondary antibodies (Organon 
Teknika Corp., West Chester, PA). DNA was stained with DAPI (1 ~tg/ml; 
Accurate  Chemical  Co.,  Westbury,  NY),  and  chitin  was  stained  with 
Calcofluor (0.2 mg/ml; Sigma Chemical Co., St. Louis, MO). Stained ceils 
were viewed with a  Zeiss Axioskop fluorescence microscope and pho- 
tographed with Kodak Type 2415 Technical Pan hypersensitized film (Lu- 
micon, Livermore, CA). 
Results 
We have previously cloned the IPL2 gene (Chan and Bot- 
stein, 1993). Molecular analysis of IPL2 described below re- 
vealed that IPL2 is identical to BEM2 (Bender and Pringle, 
1991; Zheng et al.,  1993,  1994),  which has been indepen- 
dently cloned in Alan Bender's laboratory (Peterson et al., 
1994).  For this reason, IPL2 will be referred  to as BEM2, 
and the ip12-1 mutation will be referred to as bern2-101 in this 
and future reports. 
bern2-101 Mutants Are Defective in Bud Site Selection 
and Polarized Cell Growth 
We have previously shown that bem2-101 mutant cells be- 
come arrested as large,  unbudded cells  when incubated at 
37°C (Chan and Botstein, 1993). To determine whether this 
arrest is associated with defects in cell surface growth, we 
examined the deposition of cell wall chitin in diploid wild- 
type  and  bern2-101 mutant  cells  by  Calcofluor  staining 
(Hayashibe and Katohda, 1973). At 26°C, chitin-staining in 
these cells was restricted mostly to bud scars, which define 
previous bud sites. For '~95 % of wild-type cells, these bud 
scars were found exclusively near the two poles, indicative 
of the expected bipolar budding pattern of diploid cells (Fig. 
Kim et al.  Yeast Ipl2/Bem2 GAP and Cellular Morphogenesis  1383 Figure 1. Cytological examination of the bem2-101 mutant. Wild-type (DBY1830) (a-c) and bern2-101 (CCY-D1) (d-i) diploid cells grown 
at 26°C (a-f) or for 2 h at 37°C (g-i) were stained with Calcofluor (b, e, and h) or anti-actin antibodies (c, f, and i). The DIC images 
(a, d, and g) and Calcofluor-staining images were obtained from the same cells. The arrows in i highlight small-budded cells that have 
uniform distributions of actin patches. All cells are shown at the same magnification. 
1, a and b). In contrast, the localization of  bud scars was ran- 
domized in >75 % of hera2-101 cells (Fig.  1, d and e). After 
a 2-h incubation at 37°C, the chitin-staining pattern of wild- 
type cells remained unchanged (data not shown), whereas 
that of bern2-101 cells was greatly altered (Fig.  1, g and h). 
Chitin-staining  was no longer restricted to bud  scars;  in- 
stead, many bern2-101 cells became brightly and uniformly 
stained, indicating delocalized chitin deposition and loss of 
cell polarity. This delocalized growth resulted in large, round 
cells that were mostly unbudded. Thus, bern2-101 cells are 
defective in bud site selection at the permissive growth tem- 
perature and are defective in polarized cell surface growth 
at the restrictive growth temperature. This dual defect is also 
exhibited by some cdc24 mutants (Sloat et al.,  1981). 
bern2-101 Mutants Are Defective in Organization 
of the Actin Cytoskeleton 
Since the actin cytoskeleton  plays an important role in polar- 
ized cell surface growth and chitin localization (Novick and 
Botstein,  1985;  Drubin et al.,  1988,  1993;  Haarer et al., 
1990; Johnston et al.,  1991), we examined this structure in 
wild-type and bent2401  cells by anti-actin immunofluores- 
cence microscopy. At 26°C,  wild-type and bern2-101 cells 
had  similar actin-stainlng patterns,  characterized by actin 
cables that run along the mother-bud axis and cortical actin 
patches that are concentrated in areas of active cell growth 
(i.e., buds and presumptive bud sites) (Fig. 1, c and  f). Thus, 
even though bern2-101 cells are defective in bud site selection 
at 26°C, they are not noticeably defective in the organization 
of the actin cytoskeleton at this temperature. After a 2-h in- 
cubation at 37°C, the actin-staining pattern of  wild-type cells 
remained  unchanged  (data  not  shown),  whereas  that  of 
bern2-101 cells was greatly altered (Fig.  1 i).  Actin cables 
were no longer detectable and cortical actin patches became 
uniformly distributed throughout the bern2-101 cells, which 
were predominantly enlarged and unbudded. For the small 
number  of bern2-101 cells  that  remained  budded,  actin 
patches were often not concentrated in the buds. Thus, loss 
of cell polarity and delocalization of chitin deposition are as- 
sociated with a failure to organize an asymmetric, polarized 
actin cytoskeleton in bern2-101 cells at 37°C. 
BEM2 Encodes a Protein that Is Required for Growth 
at Elevated Temperatures 
To elucidate the cause of  the defects described above, we car- 
ried out a molecular analysis of the previously cloned BEM2 
gene (Chan and Botstein,  1993). BEM2 was localized to a 
region that spans over 4.2 kb (Fig. 2). Interestingly, the plas- 
mid pCC42,  which does not contain the entire predicted 
BEM2-encoding  sequence, can complement the "Is- pheno- 
type of a bern2-101 mutant. This apparent discrepancy will 
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Figure 2.  Functional localization of the cloned BEM2 gene. The 
ability (+) or inability (-) of the different URA3-CEN plasmids 
(containing the DNA fragments shown) to complement the tem- 
perature-sensitive growth phenotype of a bem2-101 mutant at 37°C 
is listed. The plasmid pCC42 contains additional yeast sequence 
present to the left of the NruI site. The asterisk denotes the BamHI 
site that is not normally present but was created in pCC393 for the 
purpose of constructing pCC394, which has the sequence between 
the BamHI and XbaI sites replaced by the LEU2 gene. The location 
and orientation of  the predicted BEM2 open reading frame is repre- 
sented by the arrow. 
be discussed below. Sequencing of  the BEM2 region revealed 
a long open reading frame (Fig. 3) that potentially encodes 
a protein of  2167 amino acids, with a pI of 8.4 and a predicted 
molecular mass of 246 kD, which is consistent with the ap- 
parent molecular mass (>200 kD) of Bem2p as determined 
by immunoblotting (data not shown). A search of the Gen- 
Bank database revealed no protein with primary sequence 
identical to that of the predicted Bem2p. 
To determine the bem2-null mutant phenotype, a diploid 
yeast strain with one of its two BEM2 genes replaced by the 
LEU2 gene was constructed (see Fig. 2 and Materials and 
Methods).  In this  construction, codons  115-2144,  repre- 
senting 94 % of the BEM2 coding sequence, were removed. 
Sporulation and tetrad analysis of this heterozygous (BEM2/ 
bem2-AIO3::LEU2 leu2/leu2) diploid strain (CBY1830-30) 
showed that all four spores per tetrad were viable at 26°C 
on rich YEPD medium, indicating that BEM2 is not essential 
for  cell  viability  at  this  temperature.  However,  a  Leu  ÷ 
spores (carrying the bem2-AIO3::LEU2 mutation) gave rise 
to smaller colonies, indicating that deletion of BEM2 results 
in a slower growth rate at 26°C. bem2-AIO3::LEU2 cells are 
also  temperature-sensitive for growth  at  33°C  on  YEPD 
medium,  and this temperature sensitivity can be partially 
suppressed by the presence of 1 M sorbitol (Fig. 4), suggest- 
ing that bem2-AIO3::LEU2 cells may be osmotically fragile 
and prone to lyse at this elevated temperature. This is consis- 
tent with  our previous observation that bem2-101 mutant 
cells look abnormal at 37°C when examined by phase con- 
trast  microscopy,  some  appearing  to  have especially en- 
larged  vacuoles  (Chan  and  Botstein,  1993).  Indeed,  the 
Ts- growth phenotype of bem2-101 mutants also can be sup- 
pressed by the presence of 1 M  sorbitol (Fig. 4).  Overall, 
the  mutant  phenotypes  caused  by  bem2-AIO3::LEU2 are 
similar to, but more severe than, those caused by bern2-101, 
suggesting that the latter mutation does not result in a total 
loss of BEM2 function (at temperatures below 35°C, the re- 
strictive temperature for bem2-101 mutants).  The fact that 
yeast cells lacking BEM2 are viable at 26°C, but not at 37°C, 
suggests that localization of cell growth to selected bud sites 
does not absolutely require the function provided by Bem2p 
at  26°C.  Alternatively,  this  function  may  be  (partially) 
provided by other gene products at this temperature (but not 
at 37°C). Indeed, at least four other genes (BEM3, DBM1, 
LRG1 and YBR1728) encoding proteins related in sequence 
to Ipl2p are present in yeast (Doignon et al.,  1993; Zheng 
et al.,  1993,  1994;  Miiller et al.,  1994;  our unpublished 
results). 
Bem2p Has Sequence Homology with 
GTPase-activating Proteins 
Analysis of the predicted Bem2p sequence revealed two in- 
teresting features. First, the amino-terminal 310 residues of 
Bem2p is very rich (36%) in serine and threonine. The func- 
tional significance of this is unknown, but it is interesting to 
note that human Bcr described below also contains a region 
rich in these two amino acids. Second, the carboxyl-terminal 
203 residues of Bem2p is homologous to sequences found in 
a large family of proteins (Boguski and McCormick, 1993), 
including human Bcr (Heisterkamp et al.,  1985; Hariharan 
and Adams,  1987; Lifshitz et al.,  1988), chimaerin (Hall et 
al.,  1990,  1993),  CDC42GAP (Barfod et al.,  1993),  rho- 
GAP (Lancaster et al.,  1994),  the rat RasGAP-associated 
protein p190  (Settleman et al.,  1992b),  and yeast Bem3p 
(Zheng et al., 1993, 1994), Lrglp (Miiller et al.,  1994), and 
Ybr1728p (Doignon et al.,  1993). The sequence homology 
with human Bcr is highest (35 % identity) and that with yeast 
Bem3p, Lrglp, and Ybr1728p is lower (26%, 25 %, and 29% 
identity,  respectively).  The Bem2p-related domains  from 
five of these eight proteins have been shown to function in 
vitro  as  GTPase-activating proteins  that  are  specific  for 
members of the Rho-subfamily of Ras-related small GTP- 
binding proteins (Diekmann et al.,  1991; Settleman et al., 
1992a; Barfod et al.,  1993; Chen et al.,  1993a, b; Hall et 
al., 1993; Ridley et al., 1993; Zheng et al., 1993, 1994; Lan- 
caster  et  al.,  1994).  Thus,  Bem2p  may  also  serve as  a 
GTPase-activating protein (GAP) in vivo. 
bern2 Mutant Phenotypes Can Be Suppressed 
by Expression of the GAP Domain from Bem2p or 
Human Bcr 
To determine the biological significance of the sequence ho- 
mology found between Bem2p and the different (putative) 
GAPs, we tested whether bem2 mutant phenotypes can be 
suppressed by expression of the putative GAP domain from 
wild-type Bem2p or human Bcr. For this purpose, high copy 
number plasmids that allowed expression of the carboxyl- 
terminal  287  residues  of Bem2p  (containing the  putative 
GAP  domain)  or  the  carboxyl-terminal  304  residues  of 
human Bcr (containing the previously demonstrated GAP 
domain [Diekmann et al.,  1991; Ridley et al.,  1993]) under 
the  control of the  TDH3 promoter were  introduced into 
bem2 cells.  Our results  showed that bern2-101 and bem2- 
AIO3::LEU2 cells containing either plasmid could grow at 
37°C (Fig. 5; data not shown), indicating that expression of 
the putative GAP domain from Bem2p or the previously 
demonstrated GAP domain from Bcr can suppress the Ts- 
growth phenotype of bern2 mutants. Furthermore, in our ini- 
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TCCTGAAACATATTCC  CCTCGGT  GAAACACGCTC  TTGAAAATGACCTGAGAACACAAGATATCAGACGGCTCTTGTTGCACAAAAAACAAAAACAAAAGAAGCAAGCTACGTTGCAGCCA 
CTGGTACTGT•TGCTAA•TCAAACATTCTTTTTCATTTTTAATATACAGATTTCGTATTCTCCCGTTCCCC.CTATACGCAATTTTCTTTCTTTTTTTTCCCTCTTTGGTTAGGAGACTGC 
AGATCAGTCCCATTTT  TTCCAACAGAACAAACAAGCAAACGTTTCAGTTTAAAAGAACACACGGTCGTCGTGCCTTTTCTGGATAGACACAAAAAAAACAAATAACGAAGCAGGAGTCTA 
ATGAAAGGTCTTCTCTGGTCTAAGAACAGGAAATCTTCAACGGCCAGTGCTAGTTCAAGCTCAACTTCCACGTCTCATAAGACAACTACTGCGTCTACAGCATCGTCGTCGTCGCCGTCA 
M  K  G  L  L  W  S  K  N  R  K  S  S  T  A  S  A  S  S  S  S  T  S  T  S  H  K  T  T  T  A  S  T  A  S  S  S  S  P  S 
TCATCCTCTCAAACTATTCGAAACTCGACAAGCGGTGCTTCTCCATACATGCATTCCCACCATCACCATGGCCAGGGACACAGTCACCACAGAGGGGAAGACAACAACAGAGATAAGAGA 
S  S  S  Q  T  I  R  N  S  T  S  G  A  S  P  Y  M  H  S  H  H  H  H  G  Q  G  H  S  H  H  R  G  E  D  N  N  R  D  K  R 
AAAAGCTCCG  TATTTC  CACCCTCCAAGCAGTACACATCCACTAGTTCCAGTCAGGTGAACTTGGGGATGTATCATTCGGATACTRACACCAGATCTTCTAGAAGCATAGC•TCTACGCTA 
K  S  S  V  F  P  P  S  K  Q  Y  T  S  T  S  S  S  Q  V  N  L  G  M  Y  H  S  D  T  N  T  R  S  S  R  S  I  A  S  T  L 
AAAGACGATT  CTCCGT  CTGTCTGCTCCGAAGATGAAATAAGCAATTCTTCTAGCCAGAAGTCCAATGCCCAGGATGAGACTCCCATTGCGTA•AAGAAGAGTGCCCATTCGAAAGACTCA 
K  D  D  S  P  S  V  C  S  E  D  E  I  S  N  S  S  S  Q  K  S  N  A  Q  D  E  T  P  I  A  Y  K  K  S  A  H  S  K  D  S 
TTGTTGCCTTCACGTTCCTCGTCTTTATCACCTCCTCAGTCT•GATGTAGCACTGGAACTACGCTAGAGAAATCGTTGAACACTTCAGGTAT•AGTAACAGTAG•GGCACTAATAATAAC 
L  L  P  S  R  S  S  S  L  S  P  P  Q  S  R  C  S  T  G  T  T  L  E  K  S  L  N  T  S  G  I  S  N  S  S  G  T  N  N  N 
AATAGCAATAATAACAACGATAACGAGCAAAAGCAAAGAAATGTTATCCACTTAAACTCTGAAAAC  TATGATACAACTGTTTTTAAGACTGGATGGGTTAATAAGTCCCATGGCCAGACT 
N  S  N  N  N  N  D  N  E  Q  K  Q  R  N  V  I  H  L  N  S  E  N  Y  D  T  T  V  F  K  T  G  W  V  N  K  S  H  G  Q  T 
GTT  GCTACAAACTATAATAGCT  CAATGACAGCCCCTT  CCTCTTCCTCTTCGTCCTCCTCTCAGAATCTCC GTAATGATGC  GTATTC  TAGAAACAGGGAAAGCAGGTTTTATGGGAACGAC 
V  A  T  N  Y  N  S  S  M  T  A  P  S  S  S  S  S  S  S  S  Q  N  L  R  N  D  A  Y  S  R  N  R  E  S  R  F  Y  G  N  D 
GGT  TCGTCTTTAAAAAATGATGACAGCAGTAGTACTACGGCCACTAACAGTGGCAATGATGTGGCCTCAGCAAGAAC•CAGCATGGCTATAGATCCTCAAATGCTAGTACCTGATTACCGT 
G  S  S  L  K  N  D  D  S  S  S  T  T  A  T  N  S  G  N  D  V  A  S  A  R  S  S  M  A  I  D  P  Q  M  L  V  P  D  Y  R 
CTTTATAGGGCTCAAT  TGAAAGGTTGCGTTCTCAACC  TTTACAAAAGTGGTTTGAATAGTAACATTAAGTTTTTTGATCCAACTTTACCAGCTTCAAATAGTAGTATAC.CAAATGAAAAc 
L  Y  R  A  Q  L  K  G  C  V  L  N  L  Y  K  S  G  L  N  S  N  I  K  F  F  D  P  T  L  P  A  S  N  S  S  I  A  N  E  N 
CATCAACAGAAAAAACAACAAACAAACAACCAAGCACAAGCGGAAGCTCTGCACCAAAAGCAATCATTTGGCCAAATGGGTGAACCTATTACACT  GGACCTGAAGTATTTATCT  GAAGTT 
H  Q  Q  K  K  Q  Q  T  N  N  Q  A  Q  A  E  A  L  H  Q  K  Q  S  F  G  Q  M  G  E  P  I  T  L  D  L  K  Y  L  S  E  V 
TACCCGCACC  CAGATTTAAGACAAGACAG  TGATGGTAAAATTATATCAGGCACAATAGAAAGTTTATGTCA•ACAGTCTTATTTTA•CCCGGTCCAAAGCAATCGGACGTACCTAATGAG 
Y  P  H  P  D  L  R  Q  D  S  D  G  K  I  I  S  G  T  I  E  S  L  C  H  T  V  L  F  Y  P  G  P  K  Q  S  D  V  P  N  E 
AAATCATTAT  CTAAGACACATAGAGCTGTTATTAATC TGTTATTGATGTTTCCATTACTAGATCAT TTCATTAAGTTTCTAAAGGTATTCAACCAATT CGGTCTTTCTTTTACCAAGAAT 
K  S  L  S  K  T  H  R  A  V  I  N  L  L  L  M  F  P  L  L  D  H  F  I  K  F  L  K  V  F  N  Q  F  G  L  S  F  T  K  N 
AAATCAAGATTGACAAATAATTC CACACAATTCTACAACATATCCCCTGCTGTCGATGACTCCATGACTCAAAGATTAGCTTTAACTGCTAAAAcAATCCTTGATGTATTTCCGGGATTT 
K  S  R  L  T  N  N  S  T  Q  F  Y  N  I  S  P  A  V  D  D  S  M  T  Q  R  L  A  L  T  A  K  T  I  L  D  V  F  P  G  F 
TTGCT  GGATGAACCAAT  GCT  GAAGACTATAATTT  •CTTATTAGATACTATATCTTTGCATAACGATGAAATTTCCAACAATTTGAAAATTAAAAT•GCCAATAAACATAACGAATTAATG 
L  L  D  E  P  M  L  K  T  I  I  S  L  L  D  T  I  S  L  H  N  D  E  I  S  N  N  L  K  I  K  I  A  N  K  H  N  E  L  M 
AAACTTACCGCATTCACTCGATCTCTTCCAATGGCAACATCATCTACACATGAATTAGAGATTATATTGGATCCAAGTCATTTCCTGTCT  TTAGACATTACAACATTGGCTGATGAAGTT 
K  L  T  A  F  T  R  S  L  P  M  A  T  S  S  T  H  E  L  E  I  I  L  D  P  S  H  F  L  S  L  D  I  T  T  L  A  D  E  V 
CATCATATCAATTTAAAGTT  TGATAAAGTATGGGCACCGAAATTTGACTATTCTCTGCTGTATGATTCGAAGT  TTATTAATCGAAGAATTGTC  TCGTTAAATCCATTGGTATTCAACAAC 
H  H  I  N  L  K  F  D  K  V  W  A  P  K  F  D  Y  S  L  L  Y  D  S  K  F  I  N  R  R  I  V  S  L  N  P  L  V  F  N  N 
GACCAAAATATCCATTTTCTTGGAAGC~CTACTAATATCACATTTATTTCCAACAAAT  CCT  GAGTTTAGTAAAAAAGTGACT  CCAAAAGTGAGAGCTGAGTTATTAGATAAATGGGTCCAA 
D  Q  N  I  H  F  L  G  R  L  L  I  S  H  L  F  P  T  N  P  E  F  S  K  K  V  T  P  K  V  R  A  E  L  L  D  K  W  V  Q 
ATTGGCTGTAGATTTGAACATTTAGGAGACATGGTATCATGGCTAGCTGTCGCCACTATCATTTGTTCAATTCCTGTACTAAGGTCATCTTCATGGAAATATGTTCCTGATCAGTcATTG 
I  G  C  R  F  E  H  L  G  D  M  V  S  W  L  A  V  A  T  I  I  C  S  I  P  V  L  R  S  S  S  W  K  Y  V  P  D  Q  S  L 
AAAACTATTTTTAAAGATTGGGTTCCTACCATTATTCAGTTAGAGAGG•GACAAAGGACATCTAAATCTACAAGTAGTGTTTTCATACTCG•TCCT•CAAATCTGGATGACGACTTTACG 
K  T  I  F  K  D  W  V  P  T  I  I  Q  L  E  R  R  Q  R  T  S  K  S  T  S  S  V  F  I  L  A  P  P  N  L  D  D  D  F  T 
AGAGCTAACGTGATTTCTTATTTTGG•GATTTATTAATTCATGCTGATGATTTACCATCTGATACGAAATT•AAGTACTTGGAAAAGAAAATTAACAGAACAAAAAACC`CTTTTCATAAA 
R  A  N  V  I  S  Y  F  G  D  L  L  I  H  A  D  D  L  P  S  D  T  K  F  K  Y  L  E  K  K  I  N  R  T  K  N  A  F  H  K 
TGGCAACAAAGATTACAAGCAATCGACTCTACGAGACATAAAACTAATTCGACAGAAAACGTCAGGGATAATGATTCTCCTAATAAC  GTTGTTTATCAGCTCTGGAAATTTCATTTATCA 
W  Q  Q  R  L  Q  A  I  D  S  T  R  H  K  T  N  S  T  E  N  V  R  D  N  D  S  P  N  N  V  V  Y  Q  L  W  K  F  H  L  S 
CAACCTCC  GTTGAACATTGAAGGAATAATGAAATTAAGTGTCCAACACGAACCTCCAATAATCGACCAGAAAGCGTATTCTACTATTGGTTCTCAAAGGAGTGCTTTAGTAACTGGAAGT 
Q  P  P  L  N  I  E  G  I  M  K  L  S  V  Q  H  E  P  P  I  I  D  Q  K  A  Y  S  T  I  G  S  Q  R  S  A  L  V  T  G  S 
TATTTACCCATTTTATTCAATGAACTATTCCCAAATTATT•ACTATTTCCTAAGAATACATTAGTGGGTGCTGCCAGTGATGCGAAGTTGCCGcCTCCAAGATCATC•GCGCGCcTCTCA 
Y  L  P  I  L  F  N  E  L  F  P  N  Y  S  L  F  P  K  N  T  L  V  G  A  A  S  D  A  K  L  P  P  P  R  S  S  A  R  L  S 
AAATCACTTTCAATCAGTGAACCAATTCCAATAGCTTCAAACAGTCACACTATGGC•CTCATTAACAGATGATGcTATGTCCTCAAAAAATGATAATAATAAAGTTACAGGTGTTGGAAAA 
K  S  L  S  I  S  E  P  I  P  I  A  S  N  S  H  T  M  G  S  L  T  D  D  A  M  S  S  K  N  D  N  N  K  V  T  G  V  G  K 
ATTGACGGACCTGTGATCAAAGACATGTCGTCAAAACAAT CAAATAAACAGAGAC  TATTAAAATCT  GTGAGAGATGTTTTTAATATT  GACATGGATGTGTTTCATATATCAGATGAGTTA 
I  D  G  P  V  I  K  E  M  S  S  K  Q  S  N  K  Q  R  L  L  K  S  V  R  D  V  F  N  I  D  M  D  V  F  H  I  S  D  E  L 
GTATTTAAATCGGTATACGATAATGATGGTAAATCCCGTC CTGCTAGTATGGTCATAGAAACACCAAAGAGATTCTCACAACACTCT TCCATGCTTATTAATAAT  CCAGCTACTCCAAAC 
V  F  K  S  V  Y  D  N  D  G  K  S  R  P  A  S  M  V  I  E  T  P  K  R  F  S  Q  H  S  S  M  L  I  N  N  P  A  T  P  N 
CAAAAGATGAGAGATTCCTTGGATACCACTGGAAGACTAAGTAAGACATTAGAAAATATGGACTTT  TTCAACAATATTGGTCAAGTATCAGATTCACTAAAAGAATCGAT TATTCGTGTC 
Q  K  M  R  D  S  L  D  T  T  G  R  L  S  K  T  L  E  N  M  D  F  F  N  N  I  G  Q  V  S  D  S  L  K  E  S  I  I  R  V 
GTATTGAAATCGTCGT  CGCTAGAAAAGATTTTTGATTTACT GGTATTAACTTCAAATATCTTTTCAAAATTGGTAGACACTAAAGACCTT  GAGAATTATTACTATCATCAAAGACAAAGG 
V  L  K  S  S  S  L  E  K  I  F  D  L  L  V  L  T  S  N  I  F  S  K  L  V  D  T  K  D  L  E  N  Y  Y  Y  H  Q  R  Q  R 
GGTCATTCTACCAGAGGGCTTTCCGATGATAACATAGGACTACTAGATTAT  GCATTCGTTAAACTAACTATGGACAATGATATTTTCACAGAAACATTCTTCAACACTTATAAAAGCTTT 
G  }{  S  T  R  G  L  S  D  D  N  I  G  L  L  D  Y  A  F  V  K  L  T  M  D  N  D  I  F  T  E  T  F  F  N  T  Y  K  S  F 
Figure 3. Nucleotide sequence of the BEM2 region and predicted sequence of the Bem2 protein.  The upstream and downstream in-frame 
stop codons are shown by asterisks.  These sequence data are available from EMBL/GenBank/DDBJ  under accession number Z35159. 
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AC  TACTACAACTACGGTAT  TAGAAAATAT  GGCA~C  GGTATGTT  GGTGCAAAGAGT  TGCAGCGTGT  CAATTT  CCAAGATT  TTAGATCGCAG  TGAT  GATTCTAAAAT  GAAGATARATGAG 
T  T  T  T  T  V  L  E  N  M  A  K  R  Y  V  G  A  K  S  C  S  V  S  I  S  K  I  L  D  R  S  D  D  S  K  M  K  I  N  E 
GATACAAATTTAGTGTC  CT  C  TT  CATTATACGACCAAAATTTTCCT  GTTTGGGATATGARAGTAACTGAC  GATGAA~TAAACCTTATTTATAT  GGCA~TC  CAAATC~G 
D  T  N  L  V  S  S  S  L  Y  D  Q  N  F  P  V  W  D  M  K  V  T  D  D  E  N  I  N  L  I  Y  M  A  K  I  Q  I  G  A  A 
GAAGC  TATACTACATTTAGT  GA~TCATTACT  CTGACTTTACTGACGATTTATGTAACAAC  TCTACT  CTATTGGATATTATA~TAATGGAA~A~  CACT  ~CT 
E  A  I  L  H  L  V  K  N  H  Y  S  D  F  T  D  D  L  C  N  N  S  T  L  L  D  I  I  K  I  M  E  Q  E  V  S  T  E  W  P 
ACGCGAATTGCAAACT  CAAAGT  TACAAAAAAGCCTAC  CAGAAAATTTT  GTGATT  GAAACAGAAAATTTGT  TGACTACGTTAACT  GATCTATTTCAT  GGTAT  TAAA~ATAC~G 
T  R  I  A  N  S  K  L  Q  K  S  L  P  E  N  F  V  I  E  T  E  N  L  L  T  T  L  T  D  L  F  H  G  I  K  S  A  Y  Q  K 
CAACTATACAGACCTAT  TGG  TGTCAATAGAACTCAGAAGAGAATAACT  GACATTT  TGAATT  CCTTTAACACATTCTCTTTTACAGATCTTAACAACAT  CAT  T  GATGATCCTTC  CTTTAGC 
Q  L  Y  R  P  I  G  V  N  R  T  Q  K  R  I  T  D  I  L  N  S  F  N  T  F  S  F  T  D  L  N  N  I  I  D  D  P  S  F  $ 
GAT  GACATGATTAGAT  CTTT  TCAAAAGTTACACTCAAC  CAATTAC  GAAGATATAC  TAGAAT  GGATCTACCAGTTAGATAACTTTAT  TTCTAAGAAGTTCAAT  TTAGT  T  TCTAA~T 
D  D  M  I  R  S  F  Q  K  L  H  S  T  N  Y  E  D  I  L  E  W  I  Y  Q  L  D  N  F  I  S  K  K  F  N  L  V  S  K  K  D 
TGGATAGTTCTTTTCCAGGAGTTGGAATTGCTTTCAAAGGAATCTCTGGTCTCTTTTTTCAATTATCCGCTACATTTTAAGTCAAGCAAATTGATAAACCCCGGATATTTGCAATTGCAC 
W  I  V  L  F  Q  E  L  E  L  L  S  K  E  S  L  V  S  F  F  N  Y  P  L  H  F  K  S  S  K  L  I  N  P  G  Y  L  Q  L  H 
GAGTTTGAAAT  TT  C  CAATC  TTTTTAC  TT  G  GATTT  C  TACAT  T  GATTC  TTAAGGATGATAATGGTACGGAGAGT  C  TTTTTTT  T  GAAAAACTACCACAATC  TATAAAATT  GTTAATAAAGTTA 
E  F  E  I  S  N  L  F  T  W  I  S  T  L  I  L  K  D  D  N  G  T  E  S  L  F  F  E  K  L  P  Q  S  I  K  L  L  I  K  L 
CACACGAGTCTAACTACGTTTTTCGTGATGGAAATTTCAAACGTCAACAAAAGCAGTAGTGAAAGGTTAACTACTTGTAAAGTTATATTACAAATTTTGAACTACATCCGCTGGAAAAAC 
H  T  S  L  T  T  F  F  V  M  E  I  S  N  V  N  K  S  S  S  E  R  L  T  T  C  K  V  I  L  Q  I  L  N  Y  I  R  W  K  N 
GGAAGTTT  GGATTTAT  TTGATTCAGAGGAGGATGAAAGTC  C  TCATGCTATTT  GTC  CACACATT  CCAGCTTTTATTGAAAC  T  GCTAT  T  GC  G  CATGC  CATAATATCACCAGAGTC  TAGAAAC 
G  S  L  D  L  F  D  S  E  E  D  E  S  P  H  A  I  C  P  H  I  P  A  F  I  E  T  A  I  A  H  A  I  I  S  P  E  S  R  N 
TATC~AACTTTCGTGGATCAAAGCTTCTGAAA~CTTTCGGA~CCTACTAAAGGAACCCA~TCTAAGATCGATTAGTAACGTTTTAGAGAAGATAGATGACATACATAT~TTc 
Y  E  L  S  W  I  K  A  S  E  K  L  S  D  P  T  K  G  T  Q  N  L  R  S  I  S  N  V  L  E  K  I  D  D  I  H  I  K  R  F 
ATTGAGATTGATGATGTATTCAGCA~CTGCAAC~AATTTATGCCCCTGCCCTGGTTGGTTCATTTCAAGGTTACTAGAAATATCTCAGTTTGTCCCTAACATGAGTATCACTAATTCG 
I  E  I  D  D  V  F  S  K  N  C  K  N  L  C  P  C  P  G  W  F  I  S  R  L  L  E  I  S  Q  F  V  P  N  M  S  I  T  N  S 
AAACTTATTAATTTTGACA~GGAGATTTGTTAACAACATAATATCTAATGTCTTGGATTTAATTCCGAACGAAAGGGAGTTTCCACTTGATATTGAAATGAGT~C~T~CG 
K  L  I  N  F  D  K  R  R  F  V  N  N  I  I  S  N  V  L  D  L  I  P  N  E  R  E  F  P  L  D  I  E  M  S  D  E  N  P  S 
AAAAGAAC  TACAT  TTGGCC  GCAT  TC  TGTT  CAATAATT  T  TGAAGAT  GTTAATAAAGTATACAGAAAGAAGACTAAAAAAGTATCAGAATCAGAAGC  C  ATATC  GGAGAGATTTCAA~G 
K  R  T  T  F  G  R  I  L  F  N  N  F  E  D  V  N  K  V  Y  R  K  K  T  K  K  V  S  E  S  E  A  I  S  E  R  F  Q  E  Q 
GGAGTATTTAATGAAATACTAGTCAATGAAATTGA~TAAAGAGGGAAGCCAGAAAATTAGAGGTTTTACTCGATCAAGAAAAGATCTTGAAGAACTCTGCTGCTTTACAT~CC 
G  V  F  N  E  I  L  V  N  E  I  E  K  I  K  R  E  A  R  K  L  E  V  L  L  D  Q  E  K  I  L  K  N  S  A  A  L  H  Q  A 
GTTCCGAAAAAGAATAGC•AAGTCTGTTATTATCTCAGGTACTCATAGTGACAACGATCATAGCTATAATATCAATAAGAACACCGGTCAAACGCCTTCTCTAGGTAGTGTTATGGAAAGC 
V  P  K  K  N  R  K  S  V  I  I  S  G  T  H  S  D  N  D  H  S  Y  N  I  N  K  N  T  G  Q  T  P  S  L  G  S  V  M  E  S 
AATAATTCAGCAAGGAATAGAAGA~ATTcAAGGGCCTCCTTTTCCACAAATAGATCATCAGTAGTGTCAAATTCCAGCCATAATGGTGTTAGT~TA~T~T~C~ 
N  N  S  A  R  N  R  R  D  S  R  A  S  F  S  T  N  R  S  S  V  V  S  N  S  S  H  N  G  V  S  K  K  I  G  G  F  F  R  R 
CCATTTTCAATCGGTGGATTCAACACATCCAGTTCTAATTATTCACTCAACAGTATATTATCGCAAGAAGTTTCAAGTAACAAATCCATTCTACCAAGTATACTTCCAGAGGTTGATTCC 
P  F  S  I  G  G  F  N  T  S  S  S  N  Y  S  L  N  S  I  L  S  Q  E  V  S  S  N  K  S  I  L  P  S  I  L  P  E  V  D  S 
ATGCAACTACACGACTTAAAACCTAGTTATAGTTTGAAGACCTTTGAAATCAAGTCAATAATGGAAATAATCAATCACAGAAACATTCCGGCTTACTACTATGCGTTCAAGATAGTTATG 
M  Q  L  H  D  L  K  P  S  Y  S  L  K  T  F  E  I  K  S  I  M  E  I  I  N  H  R  N  I  P  A  Y  Y  Y  A  F  K  I  V  M 
~'i~  GCCATG~TATC  T GAT"NL~.C  GGCTAG  TTCTAGT~C  C  TCACA~TC-C~TA~,~TGATC~.G G  Cr  T CCAA~  T~A~C  ~T ~TAT~T~CT 
Q  N  G  H  E  Y  L  I  Q  T  A  S  S  S  D  L  T  E  W  I  K  M  I  K  A  S  K  R  F  S  F  H  S  K  K  Y  K  G  K  T 
CATAATAAGATATTTGGGGTACCATT~EAAGACGTTTGTGAAAGAGAGAATACCTTGATACCTACAATTGTTGTGAAATTGCTGGAAGAGATT~AG~GcGT~GCTA~T~ 
H  N  K  I  F  G  V  P  L  E  D  V  C  E  R  E  N  T  L  I  P  T  I  V  V  K  L  L  E  E  I  E  L  R  G  L  D  E  V  G 
TTGTACAGAATTCCTGGTTCCATCGGCAGTATAAATGCACTAAAGAACGCATTTGACGAAGAAGGTGCAACAGATAATTCCTTTACATTAGAGGACGATAGATGGTTTGAA~CG 
L  Y  R  I  P  G  S  I  G  S  I  N  A  L  K  N  A  F  D  E  E  G  A  T  D  N  S  F  T  L  E  D  D  R  W  F  E  V  N  A 
ATCGCAGGCTGTTTTAAGATGTATTTAAGAGAGTTACCAGATTCTTTATTTTCTCATGCTATGGTGAACGACTTTACCGATTTGGCGATTAAGTATAAAGCACATGCAATGGTAAA~ 
I  A  G  C  F  K  M  Y  L  R  E  L  P  D  S  L  F  S  H  A  M  V  N  D  F  T  D  L  A  I  K  Y  K  A  H  A  M  V  N  E 
GAATACAAGAGAATGATGAATGAGTTACTCCAAAAGTTACCTACATGCTATTACCAAAcTTTGAAAAGAATTGTATTTCATTTGAATAAAGTACATCAGCAT~TGT~T~T~TG 
E  Y  K  R  M  M  N  E  L  L  Q  K  L  P  T  C  Y  Y  Q  T  L  K  R  I  V  F  H  L  N  K  V  H  O  H  V  V  N  N  K  M 
GAC  GCATCAAACTTGGCTATTGTATTTTC  CATGAGTTTTATAAACCAAGAAGACTTAGCCAACAGCATGGGGTCCAGATTAGGTGCAGTTCAGACAATCCTGCAAGATTTTATTAAGAAT 
D  A  S  N  L  A  I  V  F  S  M  S  F  I  N  Q  E  D  L  A  N  S  M  G  S  R  L  G  A  V  Q  T  I  L  Q  D  F  I  K  N 
CCAAATGATTATTTCAAGCAATAAACAATTTTCGTGGTAAATGTATACAATCCACTG•TGAGAGAGAAAAAATTTGGT•CCGCCTATCGAGGGTTTGAGTTTTATATTTTTATATTTACA 
P  N  D  Y  F  K  Q  * 
GAGAGATATAGAGC  CTTTATTCATTTTTTGTTATTAATGAAGTTTGATTTGTGAACAATTTTGATTTTGGAATTCTGCCTCTTCTCCTTG 
tial  cloning  of the  BEM2  gene,  we  isolated  the  plasmid 
pCC42, which is a low copy number plasmid that contains 
a truncated version of BEM2 (Fig. 2), missing sequences 5' 
of the Sau3A site present at codons 1818-1819 (Fig. 3). Tran- 
scription of this truncated BEM2 gene, perhaps from a cryp- 
tic promoter fortuitously located near this codon, would be 
expected to allow production of a truncated Bem2p contain- 
ing at most the carboxyl-terminal 349 residues (i.e., similar 
to the putative Bem2-GAP domain described above), bem2- 
101 cells containing pCC42 grow fairly well at 37°C, again 
suggesting  that  expression  of  the  Bem2-GAP  domain  is 
sufficient  for soppression  of the Ts-  growth phenotype of 
bern2 mutants. 
Since bern2 mutants are also defective in bud site selection 
at the permissive growth temperature of 26°C, we examined 
whether plasmids  (pCC408  and pCC438)  that express  the 
GAP  domains  could  restore  normal  budding  pattern  in 
bem2-101 cells. As shown in Table II, bern2-101 haploid cells 
exhibited a randomized budding pattern, whereas the same 
cells carrying pCC408 or pCC438 budded predominantly in 
an axial pattern, which is characteristic of wild-type haploid 
cells. The '~20% of bem2-101  cells that did not bud axially 
might have lost the plasmids during the growth of the cell 
cultures and thus did not express the GAP domains. Consis- 
tent with this idea is the observation that bern2-101 cells car- 
rying the plasmid pCC231, which contains the entire BEM2 
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following yeast strains were spotted on YEPD plates that did (+) 
or did not (-) contain sorbitol or benomyl and allowed to grow at 
the indicated temperatures for two days: BEM2 (DBY1829), bern2- 
101 (CCY416-12D), and bem2-AIO3::LEU2 (CCY374-2D). 
gene,  also  exhibited  this  residual  level  of nonaxial bud- 
ding. Thus, expression of the GAP domain from Bem2p or 
Bcr fully suppresses the randomized budding phenotype of 
bem2-101 mutant cells. 
RH01 and RH02 in High Copy Number Can 
Partially Suppress bem2 Mutations 
The Bcr-GAP domain is active in vitro towards p21 rac and 
the human homolog of Cdc42p (Diekmann et al., 1991; Rid- 
ley et al., 1993), both of which belong to the Rho subfamily 
of Ras-related small GTP-binding proteins. Five genes en- 
coding Rho-related small GTP-binding proteins have been 
identified in S.  cerevisiae-RH01,  RH02,  RH03,  RH04, 
and  CDC42  (Madaule  et  al.,  1987; Johnson  and  Prin- 
gle,  1990;  Matsui and Toh-e,  1992a).  To find out whether 
these small GTP-binding proteins interact functionally with 
Bem2p in vivo,  we examined the phenotype of bem2-101 
cells bearing high copy number plasmids that contain RHO1, 
Rtt02, RH03, Rtt04, or CDC42. Our results showed that 
an increase in the dosage of RHO1 or RH02, but not RH03, 
RH04,  or  CDC42,  partially  suppressed  the  Ts-  growth 
phenotype of  bem2401 and bem2-AIO3::LEU2 mutants (Fig. 
5, data not shown). The suppression by RttO1 and RIt02 is 
Figure 5.  Growth of a bem2- 
101  mutant  (CCY416-12D) 
carrying  different plasmids. 
Suspensions of cells carrying 
high  copy number  control 
2/z-plasmid pSM217, BEM2- 
containing  low  copy num- 
ber  CEN-plasmid  pCC231, 
BEM2-GAP-containing  high 
copy  number  2#-plasmid 
pCC408,  bcr-GAP-contain- 
ing  high  copy number 2#- 
plasmid pCC438, RHOl-con- 
taining  high  copy number 
2#-plasmid  YEpU-RHOI, 
RHO2-containing high copy number 2#-plasmid YEpU-RHO2, 
RttO1-RltO2-containing high copy number 2#-plasmid pCC743, 
or SSDl-vl-containing low copy number CEN-plasmid pCC75 were 
spotted on YEPD plates and allowed to grow at the indicated tem- 
peratures for 2 d. 
additive  in  that  simultaneously increasing  the  dosage  of 
RHO1  and RIt02  led  to  improved  suppression.  Further- 
more, the randomized budding defect of bern2-101 cells at 
26°C was also weakly suppressed by an increase in the dos- 
age of RHO1 or RH02 (Table II). These results together sug- 
gest that Rholp and Rho2p may interact functionally with 
Bem2p in vivo. 
Mutations in GRRI Can Suppress bern2 Mutations 
To identify other gene products that function with Ipl2p in 
the regulation of cellular morphogenesis, we isolated and 
characterized seven extragenic suppressors of the bern2-101 
mutation. Three of these suppressor mutations confer a Cs- 
growth phenotype at 13°C (Fig. 6). All three were found to 
be alleles of GRR/ (see below), which is known to be re- 
quired for: (a) high-affinity glucose transport (Erickson and 
Johnston, 1994;  Vallier et al.,  1994);  (b) the repression of 
many yeast genes caused by the presence of glucose in the 
growth medium (Bailey and Woodword,  1984;  Flick and 
Johnston, 1991; Vallier and Carlson, 1991); and (c) glucose- 
dependent divalent cation transport (Conklin et al.,  1993). 
These three mutations suppress the Ts- growth phenotype, 
Table 1I.  Budding Pattern of bern2-101 Haploid Cells  Carrying  Different  Plasmids 
Budding pattern (%) 
Plasmid  Relevant features  Axial  Bipolar  Randomized 
pG-3  2#,  TRP1  40  5  55 
pCC408  2#,  TRP1,  BEM2-GAP  79  5  16 
pCC438  2#,  TRP1,  bcr-GAP  81  6  13 
pRS316  CEN,  URA3  32  5  63 
pCC231  CEN,  URA3,  BEM2  80  7  13 
pCC75  CEN,  URA3,  SSDI-vl  70  6  24 
YEp24  2/~,  URA3  35  3  62 
YEpU-RHO1  2/x,  URA3,  RH01  55  4  41 
YEpU-RHO2  2#,  URA3,  RH02  57  8  35 
pCC743  2#,  URA3,  RH01,  RH02  47  4  49 
bern2-101 trpl ura3 (CCY416-12D) ceils carrying the different plasmids were grown at 26°C in supplemented SD medium (with selection for URA3 or TRPI 
present on the different plasmids) to a density of ,,o2  x  106 cells/ml,  fixed and then stained with Calcofluor. For each sample, 200 cells with at least two bud 
scars were examined. In scoring the bud scar pattern,  each mother cell body was divided into three equal sectors along its length.  Cells with an axial budding 
pattern had bud scars located exclusively in one terminal sector; cells with a bipolar budding pattern had bud scars located in both terminal, but not the middle, 
sectors;  cells with a randomized budding pattern had bud scars in the middle sector. 
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phenotype  of bem2-101 mu- 
tants by the grrl-102 mutation. 
Suspensions of the  following 
yeast strains were spotted on 
YEPD plates and allowed to 
grow at 26 or 37°C for 2 d, or 
at 13°C for 6 d: BEM2 GRRI 
(CCY802-11C),  bern2-101 
GRR/ (CCY471-13C), BEM2 
grrl-102 (CCY487-21D), and beta2-101 grrl-102 (CCY488-16A). 
Similar results were obtained with the grrl-lO1 and grrl-103 muta- 
tions. 
but not the morphological defects, of bern2-101 mutants at 
37°C (Fig. 6; data not shown). At this temperature, the bud- 
ding pattern of cell carrying bern2-101 and any one of these 
suppressor mutations is still randomized, and these cells are 
often irregular in shape. However, at 26°C, bud site selection 
is normal in •90%  of these cells (data not shown). At this 
temperature,  cells carrying these  suppressor  (grrl)  muta- 
tions are slow-growing, elongated in shape (Fig. 7 a), and 
mildly supersensitive to the microtubule destabilizing drug 
benomyl (being unable to grow in the presence of 15/~g/ml 
of  benomyl on YEPD medium). This latter phenotype is also 
shared by bem2-AIO3::LEU2  mutants (Fig. 4), and it sug- 
gests that cellular morphogenesis may play a role in deter- 
mining microtubule stability. The suppressor mutant pheno- 
types  described  above  are  recessive  and  are  not  greatly 
affected by the presence or absence of the bern2-101  mu- 
tation. 
A  number  of mutations  that  confer  an  elongated  cell 
phenotype similar to that of the  suppressor mutants have 
been described, including grrl  (Flick and Johnston,  1991; 
Vallier  and  Carlson,  1991;  Conklin  et  al.,  1993),  cdc55 
(Healy et al., 1991), tpd3 (van Zyl et al., 1992), cdc3, cdclO, 
cdc11, and cdc12 (Hartwell, 1971). Several lines of evidence 
indicate that the three extragenic suppressor mutations de- 
scribed above reside within the GRR/gene. First, mating of 
a  known Cs- grrl::LEU2 mutant (CCY450-8A) (Flick and 
Johnston, 1991) with the Cs- suppressor mutants (CCY354- 
1C, CCY355-4C,  and CCY362-7B) generated diploids that 
were Cs- for growth at  13°C  (i.e., noncomplementation). 
Second, the Cs- growth phenotype of one suppressor mu- 
tant tested (CCY363-1D)  was complemented by a low copy 
number plasmid containing the GRR/  gene.  Third, tetrad 
analysis of a diploid strain heterozygous for the suppressor 
mutation (CCY363-1C  x  CBY1829-1) showed that the sup- 
pressor mutation is very tightly linked to GRR/(76 parental 
ditypes,  0  nonparental ditypes,  0  tetratypes).  Fourth,  the 
grrl::LEU2  null mutation can suppress the Ts- phenotype 
of bem2-101 mutants at 37°C. A similar grrl:: URA3 null mu- 
tation (Flick and Johnston,  1991) also can suppress the Ts- 
phenotype of bem2-AIO3::LEU2 mutants 33°C. Thus, these 
suppressor mutations are named grrl-101, grrl-102, and grr1- 
103. Suppression of bem2-101  Ts- phenotype by grrl::LEU2 
and grrl-101  is recessive, whereas that by grrl-102 and grr1- 
103 is weakly semi-dominant. 
Since GRR/is required for the repression of many yeast 
genes  caused  by  the  presence  of glucose  in  the  growth 
medium, the loss of repression could be the reason why grrl 
mutations suppress the Ts- growth phenotype of bem2-101 
mutants,  which are typically grown on glucose-containing 
Figure 7. Cytological examination ofgrrl-102  diploid mutant ceils (CCY-D3). Cells grown at 26°C (a-d) or for 24 h at 13°C (e-h) were 
stained with Calcofluor (b and f), anti-tubulin antibodies (c and g), or DAPI (d and h). The DIC (a and e) and Calcofluor-staining images 
were obtained from the same cells; the anti-tubulin-staining and DAPI-staining images were from the same cells. All cells are shown at 
the same magnification. 
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tions that lead to the derepression of glucose-repressed genes 
in bern2-101 GRR1 mutants also to result in suppression of 
the  Ts-  growth  phenotype.  We  found  this  not  to  be  true 
because bern2-101 GRRI  mutants are still Ts- on YEP me- 
dium containing glycerol, galactose, or ratiinose, instead of 
glucose  (data  not  shown),  thus  arguing  against  the  loss 
of glucose repression as being the basis for suppression of 
bern2-101. 
grrl Mutants Are Defective in Chitin Localization 
and Cell Separation 
To better understand  the nature  of the defect seen in grrl 
cells,  we  examined  cytologically  the  grrl-102  mutant  in 
greater detail. At 26°C, the permissive growth temperature, 
budding pattern (Fig. 7, a and b, data not shown) as well as 
organization of the actin cytoskeleton (data not shown) and 
microtubules were normal (Fig. 7 c), but chitin localization 
was not. Chitin staining was not restricted to bud scars; in- 
stead, additional chitin staining was often seen, typically as 
a diffuse, broad band that goes around the circumference of 
a portion of the elongated cell (Fig. 7 b). After a 24-h incuba- 
tion at 13°C, some grrl-102 cells became slightly more elon- 
gated and many elongated cells became somewhat swollen 
at one end. About 90 % of grrl cells appeared interconnected 
and could not be separated by sonication (Fig. 7 e). However, 
these cells were readily separable after the removal of cell 
wall material by zymolyase (Fig. 7, g and h), thus suggesting 
that grrl  mutants  are  defective in  cell  separation but  not 
cytokinesis at 13 °C. The chitin delocalization defect seen at 
26°C was exaggerated at 13°C, and the diffuse chitin staining 
appeared more patchy in some cells. This patchiness may not 
be apparent in Fig.  7 f. While the organization of the actin 
cytoskeleton remained normal (data not shown), the organi- 
zation of microtubules was altered. Staining of microtubules 
by anti-tubulin antibodies became more intense; a significant 
fraction (~23 %) of grrl cells also contained microtubules 
that did not appear to be connected to the spindle pole body 
or the nucleus  (Fig.  7,  g  and h).  In spite of the observed 
microtubule defect, nuclear migration and division remained 
normal (Fig.  7 h). 
grrl cdc55 Double Mutants Are Inviable 
CDC55 encodes a protein homologous to the regulatory B 
subunit of mammalian protein phosphatase 2A.  Like grrl 
mutants,  cdc55 mutants are elongated at  14°C,  and muta- 
tions in BEM2 have been identified previously as extragenic 
suppressors of cdc55-1 (Healy et al.,  1991).  Thus, we were 
interested  in  studying the  functional  relationship between 
GRR/  and  CDC55.  To this  end,  we examined the conse- 
quence of simultaneous inactivation of both genes.  Tetrad 
analysis of a diploid strain heterozygous for grrl::LEU2 and 
cdc55::URA3  (CCY469-38A  x  CCY469-41A) revealed that 
grrl::LEU2  cdc55::URA3  double  mutants  are  inviable at 
26°C  on  YEPD  medium.  Among  36  tetrads  analyzed,  4 
tetrads produced 4 viable spores, all of which were Ura  + or 
Leu  ÷,  but  not  Ura  ÷ Leu  ÷.  22  tetrads  produced  3  viable 
spores and  10 tetrads  produced 2  viable spores.  None of 
these  viable spores were  Ura  + Leu  +.  Among the 42  invi- 
able  spores,  38  had  the  inferred  genotype of grrl::LEU2 
cdc55::URA3.  These  results  clearly  show  that  the  grrl:: 
LEU2 and cdc55::URA3  mutations together produce a syn- 
thetic  lethal  phenotype,  thus  suggesting  that  CDC55 and 
GRR/may be involved in the regulation of a common process 
(possibly one that involves protein phosphatase [2A]).  We 
also determined whether the bern2-101 mutation can be sup- 
pressed by other perturbations of protein phosphatase 2A ac- 
tivity. Our results showed that neither increased dosage of 
PPH3, PPH21, or PPH22,  which encode catalytic subunits 
of protein phosphatase 2A (Sneddon et al.,  1990; Ronne et 
al.,  1991;  Sutton et al.,  1991),  nor deletion of the PPH22 
gene can  suppress  the  Ts- growth phenotype of bern2-101 
mutants (data not shown). 
SSDI-vl Can Suppress bem2 Mutations 
In the initial attempt to clone the BEM2 gene,  two classes 
of low copy number plasmids that contain  yeast genomic 
DNA  sequences  capable  of  complementing  the  Ts-  for 
growth and random budding  phenotypes of bern2-101 mu- 
tants were isolated (Fig. 5 and Table II). One class contains 
the bona fide BEM2 gene; the other contains a different gene 
that is unrelated to BEM2 (Chan and Botstein,  1993).  Se- 
quence analysis of this latter gene revealed that it is identical 
to SSDI-vl (also known as SRK1), which was identified previ- 
ously  as a  gene that can  suppress the mutant phenotypes 
caused  by  mutations  in  SIT4 (Sutton  et  al.,  1991),  INS1, 
PDE2,  BCY1 (Wilson  et  al.,  1991),  SLK1/BCK1/SSP31 
(Costigan et al.,  1992), SLT2/MPK1 (Mazzoni et al.,  1993), 
CLN1, CLN2  (Cvrckov~i and Nasmyth,  1993),  and RPC53 
(Chiannilkulchai  et al.,  1992).  The SSDI-vl  gene also can 
suppress  the  Ts- growth  phenotype  of bem2-AIO3::LEU2 
mutants  at  35  but  not  37°C  (data  not  shown).  As  first 
reported by Sutton et al.  (1991),  we found different labora- 
tory yeast strains to have SSDI-v(1) or ssdl-d alleles on their 
chromosomes (data not shown). The molecular basis of the 
difference  between  these  alleles  is  not  known,  bern2401 
SSDI-v(1) mutants  are  Ts  ÷ for  growth  at  37°C,  bern2-101 
ssdl-d and bem2-101 ssdl-A2::URA3 mutants are Ts-, and 
bern2-101 ssdl-d mutants carrying SSDI-vl  on a  low copy 
number plasmid are Ts  ÷. All the bem2 strains used in this 
study are presumed to carry ssdl-d alleles unless otherwise 
stated. 
bem2-AlO3: :LEU2 Asit4: :HIS3 SSDI-vl Mutants 
Are Inviable 
The SIT4 gene encodes a protein closely related to, but not 
identical to, the catalytic subunit of protein phosphatase 2A 
(Arndt  et  al.,  1989).  Yeast cells  that  are  simultaneously 
deleted for SIT4 and TPD3, which encodes the regulatory A 
subunit of protein phosphatase 2A, are inviable even in the 
presence of the SSDI-v allele (van Zyl et al.,  1992).  Like 
BEM2, SIT4 is required  for bud emergence and/or growth 
(Fernandez-Sarabia et al.,  1992).  Since the SSDI-vl  gene 
suppresses the Ts- growth phenotype of bem2 mutants and 
the inviability of sit4-delefon mutants (Sutton et al.,  1991), 
We were interested in studying the functional relationship be- 
tween BEM2 and SIT4. Thus, we examined the consequence 
of simultaneously  deleting  BEM2  and  SIT4 in  a  cell  that 
contained  an  SSDI-vl  suppressor  allele.  Tetrad  analysis 
of a  diploid  strain  (CY248  ×  CCY475-19A)  homozygous 
for  SSDI-vl,  leu2  and  his3,  and  heterozygous  for  bem2- 
AIO3::LEU2  and  Asit4::HIS3  revealed  that  bem2-Al03:: 
LEU2 Asit4::HIS3 SSDI-vl  mutants are inviable at 26°C on 
YEPD medium. Among 46 tetrads analyzed, 10 tetrads pro- 
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not His  + Leu  +. 25 tetrads produced 3 viable spores and 11 
tetrads produced 2 viable spores. None of  these viable spores 
were  His  + Leu  ÷.  Among the 47  inviable  spores,  45  had 
the  inferred  genotype  of bem2-AIO3::LEU2  Asit4::HIS3 
SSDI-vl.  These results clearly show that the bem2-Al03:: 
LEU2 and Asit4::HIS3  mutations together produce a  syn- 
thetic lethal phenotype, which cannot be suppressed by the 
SSDI-vl  allele. 
Discussion 
Previous studies of S. cerevisiae mutants defective in cellular 
morphogenesis have identified two Ras-related small GTP- 
binding proteins, Rsrlp/Budlp and Cdc42p, and their regula- 
tory proteins as important components that control polarized 
cell growth in yeast. Here we show that this control also in- 
volves  the  Bem2  GTPase-activating protein,  which  may 
regulate the Rholp and Rho2p Ras-related GTP-binding pro- 
teins in vivo. 
The BEM2 gene is required for bud site selection at 26°C 
and localization of cell growth to selected bud sites at 37°C. 
Conditional bem2  mutants incubated at 37°C exhibit uni- 
form cell surface growth, disorganization of the actin cyto- 
skeleton, and they become arrested as large, round, mul- 
tinucleate, unbudded cells that are osmotically fragile. The 
carboxyl-terminal 203  residues of the predicted Bem2 pro- 
tein is homologous to sequences found in a large family of 
eukaryotic proteins, some of which have been shown to func- 
tion in vitro as GAPs for members of the Rho-subfamily of 
Ras-related small GTP-binding proteins (Diekmann et al., 
1991; Settleman et al.,  1992a; Barfod et al.,  1993;  Hall et 
al.,  1993; Ridley et al.,  1993;  Zheng et al., 1993).  Bem2p 
most likely also functions as a GAP in vivo because BEM2 
function required  for polarized cell growth (at 26°C  and 
37°C) can be fulfilled by simply expressing the GAP-domain 
of Bem2p or that of human Bcr, which is the protein most 
homologous to Bem2p identified so far. 
In animal cells, Rho-related small GTP-binding proteins 
are  involved in  controlling  the  organization of the  actin 
cytoskeleton  (Hall,  1992).  In  S.  cerevisiae,  five  genes 
(CDC42, RH01, RH02, RIt03, and RH04) encoding Rho- 
related GTP-binding proteins have been identified (Madaule 
et al., 1987; Johnson and Pringle, 1990; Matsui and Toh-e, 
1992a).  The gene product of CDC42 shares the highest de- 
gree of sequence homology with human Racl and Cdc42Hs, 
while the gene product of RH01  is most homologous to 
RhoA. The Bcr-GAP domain can function in vitro as a GAP 
for Racl  and Cdc42Hs,  but not RhoA (Diekmann et al., 
1991; Ridley et al., 1993).  Microinjection experiments also 
suggest that the Bcr-GAP domain can inhibit Racl-mediated, 
but not RhoA-mediated, processes in fibroblasts (Ridley et 
al.,  1993).  Since Bem2p can be functionally substituted by 
the Bcr-GAP domain, we might expect Bem2p also to func- 
tion in yeast as a GAP for Cdc42p, but perhaps not for Rholp, 
Rho2p, Rho3p, or Rho4p. However, this may not be true be- 
cause increased dosage of RH01 or RH02, but not RH03, 
RH04, or CDC42, can partially suppress the bem2-101 and 
bem2-AIO3::LEU2 mutations. This observation can be inter- 
preted in several ways. First, since overproduction of Rholp 
or Rho2p may result in activation of the Cdc43/Ram2 ger- 
anylgeranyltransferase  I (Qadota et al., 1992), this activation 
may somehow be responsible for the suppression of  the bem2 
mutations. Second, unusually high levels of Rholp or Rho2p 
may partially provide the function normally performed by 
another Rho-related protein whose activity is affected in 
bem2 mutants. Third, Bem2p may function in vivo as a GAP 
for Rholp and Rho2p. We favor this last possibility because 
we have preliminary results which suggest that SSDI-vl can 
suppress the Ts- growth phenotype of not only bem2, but 
also  rhol%  mutants  (our  unpublished  results).  This  in- 
terpretation is also consistent with the recent finding that the 
Bem2-GAP domain functions in vitro as a  GAP for yeast 
Rholp, but not yeast Cdc42p or human Cdc42Hs (Zheng et 
al.,  1993, 1994;  Peterson et al.,  1994). 
The identification of Rholp as a potential in vivo target of 
Bem2p is interesting because Rholp is believed to be concen- 
trated to the periphery of yeast cells where cortical actin 
patches are clustered, and because the Ts- growth defect of 
rho1-104  '~ mutants, like that of bem2 's mutants, can be sup- 
pressed by the presence of 1 M  sorbitol (Yamochi  et al., 
1994).  However,  the  mutant phenotypes of rho1-104 and 
bem2 mutant ceils are not identical. At 37°C, rho1-104 mu- 
tants become arrested as uninucleate, tiny- or small-budded 
cells that are normal in size, whereas bern2 mutants become 
arrested as multinucleate, unbudded cells that are enlarged. 
We do not know the basis for this difference, but it may be 
explained, as least partly, by our finding that Bem2p may 
also function as a GAP for Rho2p in vivo. 
The apparent discrepancy between the proposed function 
of the Bcr-GAP domain in fibroblasts and in yeast cells may 
reflect functional differences that may exist between yeast 
Cdc42p, Rholp, Rho2p, and their human counterparts, even 
though yeast Cdc42p and Rholp can be substituted in vivo 
(at least partially) by human Cdc42Hs and RhoA, respec- 
tively (Munemitsu et al., 1990; Shinjo et al., 1990; Yamochi 
et al.,  1994;  Qadota et al.,  1994).  Alternatively, the Bcr- 
GAP domain, which was expressed in yeast under the con- 
trol  of  the  strong  TDH3  promoter  without  the  amino- 
terminal 80% of the intact Bcr protein, might have lost its 
substrate specificity.  This potential problem also applies to 
most in vitro (and in vivo) studies of GAPs, which typically 
utilize truncated recombinant proteins. In this context, it is 
interesting to note that the Bem2-GAP domain constitutes 
<10%  of the full-length Bem2p. 
If Rholp and Rho2p are regulated by the Bern2  GAP in 
vivo, mutations that reduce BEM2 function should result in 
Rholp and Rho2p that are more frequently associated with 
GTP.  According to the model commonly used to explain 
the functioning of Ras-related small GTP-binding proteins 
(Bourne et al.,  1991), bem2  mutants may have excessive 
RH01 and RH02 function because GTP-bound Rholp and 
Rho2p would be in the activated state, and increasing the 
dosage of RH01 or RH02 in bern2 mutants should result in 
an exacerbation ofbem2 mutant phenotypes. This prediction 
is precisely opposite to what we observed. Thus, association 
with GTP may be insufficient for the functioning of Rholp 
and Rho2p. In addition, controlled cycling between the GTP- 
and GDP-bound states may be important, as proposed for the 
Sec4 and Sarl GTP-binding proteins (Walworth et al., 1989, 
1992; Oka and Nakano, 1994). In this model, increasing the 
dosage of RH01 or RH02 in bern2 mutants would result in 
an increased amount of Rholp or Rho2p that is GTP bound, 
which would then lead to  increased cycling between the 
GTP- and GDP-bound states due to the intrinsic GTPase ac- 
tivity of these proteins. In fact, an increase in the dosage of 
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growth defect of sec23-1 mutants (Oka and Nakano, 1994), 
which carry a  defective GAP for Sarlp  (Yoshihisa  et al., 
1993). In principle, Bem2p may also function as an effector 
of Rholp  and  Rho2p.  However,  since  overproduction  of 
Rholp or Rho2p can partially suppress the Ts- phenotype 
caused by a deletion of BEM2, Bem2p cannot be the only 
effector of these proteins. 
The mechanisms by which most Ras-related small GTP- 
binding proteins transduce signals to downstream compo- 
nents are not known. In fibroblasts,  Ras-mediated mitogenic 
signaling in response to various growth factors appears to in- 
volve upstream phosphorylation events that lead to the com- 
plexing of activated Ras with the Raf protein kinase, which 
in turn activates the MEK and MAP protein kinases (for re- 
view, see Crews and Erikson, 1993).  The latter protein ki- 
nase can be dephosphorylated and inactivated by the MKP-1/ 
PAC1 protein phosphatase, resulting in termination of mito- 
genic signaling (Sun et al.,  1993;  Zheng and Guan,  1993; 
Ward et al.,  1994).  Recently, two protein kinases that can 
bind to  GTP-bound human Cdc42Hs  or  Racl  have been 
identified (Manser et al.,  1993, 1994).  They may function 
as in vivo targets of Cdc42Hs and Racl. The Bcr protein is 
also known to have protein kinase activity in vitro (Maru and 
Witte, 1991). While proteins that clearly function upstream 
or downstream of Bem2p, Rholp, or Rho2p have not been 
identified, the genetic interactions summarized in Fig. 8 sug- 
gests that protein phosphorylation or dephosphorylation may 
also play an important role in the BEM2-mediated process. 
TPD3 and CDC55 encode the regulatory A and B subunit 
of yeast protein phosphatase 2A, respectively. Cells lacking 
TPD3 or CDC55 are cold-sensitive for growth; thesecells 
are elongated in shape and defective in cell separation at re- 
duced temperatures  (Healy et al.,  1991; van  Zyl et al., 
1992).  In  addition,  cdc55  mutants are  known to  exhibit 
delocalized cell surface chitin deposition at the restrictive 
temperature (Healy et al.,  1991), and they are especially 
proficient in undergoing pseudohyphal differentiation in re- 
sponse to nitrogen starvation (Blacketer et al.,  1993).  The 
growth phenotype of cdc55 mutants can be suppressed by 
mutations in BEM2 (Healy et al., 1991). Here we show that 
the Ts- growth phenotype of bem2-101 mutants can be sup- 
pressed by mutations in GRRI. grrl mutants have Cs- and 
morphological  phenotypes  similar  to  those  of tpd3  and 
cdc55 mutants. Yeast cells lacking both GRR/and CDC55 
exhibit a synthetic lethal phenotype. Both Grrlp and Tpd3p 
contain tandem repeats that are similar in being leucine and 
isoleucine rich (Flick and Johnston,  1991; van Zyl et al., 
1992).  This  combination of genetic  interactions,  mutant 
phenotypes,  and  sequence  similarities  observed  among 
BEM2,  CDC55, GRR1, and TPD3 suggest that GRR/ may 
also be involved (directly or indirectly) in the regulation of 
protein phosphatase (2A) activity.  In this context, it is in- 
teresting  to  note  that yeast cells  overexpressing PPH22, 
which encodes a  catalytic subunit of protein phosphatase 
2A, are elongated in shape (Ronne et al.,  1991). 
SIT4 encodes a protein closely related, but not identical, 
to the catalytic subunit of protein phosphatase 2A (Arndt et 
al.,  1989).  It is required for bud emergence and/or growth 
and SWl4-mediated accumulation of Gt cyclin RNAs (Fer- 
nandez-Sarabia et al.,  1992).  Yeast cells lacking both S1T4 
and TPD3 exhibit a synthetic lethal phenotype (van Zyl et 
al.,  1992).  BEM2 and S1T4 are related genetically in two 
protein 
phorpl~e 
GRRI  SlTd 
CDCS$  ~  /  i  TPD3 
PP2A  ~....,  PP2A 
regu;ator  3EMI  4 .....  SSJDI  festal.tot 
GAP 
.., .., 
RH0112 
G'l'Pase 
Figure 8. Summary of observed genetic interactions. Synthetic le- 
thal relationship revealed by simultaneous deletion of two genes is 
depicted by a solid line. Suppression of mutation in one gene (near 
arrowhead) by mutation in a second gene or increased dosage of 
a second gene is depicted by a single broken line or two broken 
lines, respectively. 
ways.  First,  the  SSDI-vl gene suppresses  the Ts-  growth 
phenotype  of bem2 mutants  and  the  inviability of sit4- 
deletion mutants (Sutton et al.,  1991). Second, yeast cells 
lacking both BEM2 and SIT4 exhibit a synthetic lethal pheno- 
type even in the presence of the SSDI-vl suppressor.  The 
SSD1 gene product is homologous in sequence to the Dis3 
protein  of  Schizosaccharomyces  pombe.  Cells  mutated 
simultaneously in dis3  + and dis2  ÷, which encodes a  cata- 
lytic subunit of protein phosphatase 1, exhibit a synthetic le- 
thal phenotype (Kinoshita et al., 1991). The dis3  ÷  gene can 
also function as a dosage-dependent suppressor of S. pombe 
ppel-  mutants,  which are  defective in  cell  shape control 
due to a defective Sit4-related protein phosphatase (Shima- 
nuki et al., 1993).  These observations together suggest that 
the SSD1 (and dis3  ÷) gene product may be involved in the 
regulation of protein phosphatase activity. This is an idea 
that has been proposed previously (Sutton et al., 1991; Wil- 
son et al., 1991) and is consistent with the observation that 
SSDI-vl can suppress mutations in many genes (SIT4, PDE2, 
BCY1, SLKl/BCK1/SSP31, SLT2/MPK1, CLN1, and  CLN2) 
that encode proteins involved in (the control of) protein ki- 
nase or phosphatase function. 
While we do not know the molecular mechanisms under- 
lying the genetic interactions outlined in Fig. 8, we believe 
that these interactions all point towards a likely role for pro- 
tein phosphorylation or dephosphorylation in the BEM2- 
mediated pathway or one that functionally overlaps with this 
pathway.  Mutations that inactivate regulatory subunits of 
protein phosphatases may result in increases or decreases in 
phosphatase activities towards different substrates (reviewed 
in Mumby and Walter, 1993) that can be compensated by ap- 
propriate changes in protein kinase activities.  Since both 
SSDI-vl and grrl can suppress the bem2-null mutation, the 
postulated  phosphorylation  or  dephosphorylation  event 
probably does  not occur upstream of Bem2p.  Instead,  it 
probably occurs downstream or in a parallel pathway with 
overlapping functions. In one simple model, Bem2p may 
directly or indirectly control the activity of a protein phos- 
phatase (or kinase) or a protein whose function requires ap- 
propriate  phosphorylation  or  dephosphorylation.  In  this 
context, it is interesting to note that mutational inactivation 
of components  of the  Pkcl/Sttl,  Bckl/Slkl/Ssp31,  Mkkl, 
Mkk2, and Mpkl/Slt2 protein kinase cascade results in Ts- 
growth defects that can be suppressed by osmotic stabilizing 
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viewed in Errede and Levin,  1993).  These properties are 
very similar to those of bem2 mutants.  Further identification 
of other proteins that function in the BEM2-mediated process 
should help to elucidate the relationship between these sig- 
naling proteins. 
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